WHO analyzes effectiveness of new Ebola vaccines and drugs

The World Health Organization (WHO) has gathered experts to assess potential treatments and vaccines against a rare strain of Ebola, according to the UN News Service. Three candidate treatments have been selected for clinical trials: the monoclonal antibodies MBP-134 and mafotilimab, along with the antiviral drug remdesivir.

For individuals who have been in contact with infected persons, the antiviral drug obeldesivir is being considered as a preventative measure. Additionally, two potential vaccines have been identified for further evaluation. This initiative comes as the WHO reports a significant outbreak in the Democratic Republic of Congo (DRC).

“

Five out of ten infected individuals may die. This is a very high rate.

Following a new Ebola outbreak two weeks ago in the DRC, the WHO has recorded 906 suspected infections, with 223 deaths potentially linked to the virus. As of May 28, the country confirmed 125 cases, including 17 fatalities, across the Ituri, North Kivu, and South Kivu provinces. Analysis of suspected cases is ongoing.

“

People get infected trying to help their relatives with symptoms of the disease, so families have to explain that they should not touch sick relatives.

Uganda has confirmed seven cases, including one death. Three of these cases were imported from Congo, while the others are linked to contact with infected individuals. The WHO notes that there is currently no evidence of community transmission within Uganda. The organization recommends that people in affected areas refrain from travel but does not deem international travel or trade restrictions necessary at this stage.

Anais Legrand, a WHO specialist in viral hemorrhagic fevers, explained that people often contract the virus while trying to help sick relatives, underscoring the importance of explaining to families that they should not touch infected loved ones. She stressed the critical role of prevention and timely medical attention. Legrand noted that mortality rates for this Ebola strain can range from 30 to 50 percent, meaning five out of ten infected individuals may die. However, she added that chances of recovery can be improved with proper intensive treatment and early diagnosis, encouraging people to recognize early symptoms to receive prompt care. She cited a recent case in Congo where a patient fully recovered and was discharged from the hospital.

“

The chances of recovery can be increased through proper intensive treatment and early diagnosis.